Rushit Lodaya | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Dr. Rushit Lodaya | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Associate Director at GSK, United States

Rushit N. Lodaya is an accomplished leader in vaccine formulation and drug product R&D, with over a decade of expertise in developing innovative delivery platforms for nucleic acids, adjuvants, and protein antigens. He specializes in lipid nanoparticle (LNP) formulations for RNA delivery, optimizing thermostable formulations, and advancing alternative drying technologies. His contributions include multiple patents, impactful publications, and leadership roles in cross-functional collaborations, including partnerships with organizations like the NIH. A strong advocate for innovation, Rushit has significantly influenced the fields of mRNA vaccines and adjuvant development through his research and mentorship. He emphasizes a “patent-first” strategy while promoting knowledge sharing through guest editing and academic collaborations. Dedicated to sustainability and translational research, he integrates cutting-edge science with practical applications. Rushit’s leadership, scientific contributions, and commitment to fostering talent make him a standout researcher advancing the frontiers of biopharmaceuticals and vaccine technology.

Professional Profile

Education

Rushit N. Lodaya has a strong academic foundation that underpins his expertise in pharmaceutical and vaccine research. He earned his Ph.D. from Northeastern University, Boston, as a GSK Fellow, where his research focused on developing and characterizing novel self-emulsifying adjuvant systems containing α-tocopherol. Under the guidance of Dr. Mansoor M. Amiji and Dr. Derek T. O’Hagan, he conducted innovative studies to enhance immune responses in vaccine formulations, including in vivo evaluations of adjuvants and lyophilization processes for single-vial vaccines. Prior to this, he pursued undergraduate research at Mumbai University, where he formulated and evaluated sustained-release drug delivery systems. His educational journey is marked by a blend of rigorous academic research and practical applications, equipping him with a robust skill set in formulation sciences, drug delivery, and vaccine development. This educational background laid the groundwork for his impactful career in advancing cutting-edge pharmaceutical and biopharmaceutical technologies.

Professional Experience

Rushit N. Lodaya has over a decade of professional experience in pharmaceutical and biopharmaceutical research, specializing in vaccine formulation, drug delivery systems, and lipid nanoparticle (LNP) technologies. Currently serving as Associate Director of RNA Delivery Sciences at GSK Vaccines, he leads strategies to advance mRNA delivery platforms and novel characterization tools. Previously, as an Expert Scientist at GSK, he spearheaded initiatives to optimize mRNA-LNP formulations, improve vaccine adjuvant processes, and establish external collaborations for drug product innovation. His earlier roles include significant contributions to Phase III clinical development, process transfer for GMP manufacturing, and formulation of protein antigens. At Cubist Pharmaceuticals, he worked on early-stage formulations for novel antibiotics and post-operative pain management. Rushit’s experience also encompasses academic roles, supervising Ph.D. students and guest editing for journals. His dynamic career blends technical expertise, innovative research, and leadership, driving advancements in vaccine and therapeutic development to address critical global health needs.

Research Interests

Rushit N. Lodaya’s research interests lie at the intersection of vaccine formulation science, advanced drug delivery systems, and pharmaceutical innovation. He is particularly focused on developing lipid nanoparticle (LNP) platforms for RNA delivery, optimizing their composition, stability, and scalability for clinical applications. His work extends to creating novel adjuvants and understanding their mechanisms to enhance immune responses. Rushit is also deeply invested in exploring alternative drying technologies, such as lyophilization, to achieve thermostable formulations, crucial for vaccines’ global accessibility and distribution. He is enthusiastic about tackling challenges in intracellular delivery, improving endosomal escape, and enabling co-delivery systems for therapeutic and prophylactic applications. Committed to translational research, Rushit seeks to bridge the gap between preclinical discoveries and real-world implementation, addressing pressing public health needs. His passion for innovation and sustainability aligns with his goal of advancing next-generation biopharmaceuticals and vaccines that are efficient, stable, and globally impactful.

Awards and Honors

Rushit N. Lodaya has been recognized for his outstanding contributions to vaccine research and pharmaceutical sciences through various awards and honors. As a recipient of the prestigious GSK Fellowship during his Ph.D. at Northeastern University, he demonstrated exceptional research capabilities in adjuvant systems and vaccine delivery. His innovative work has earned him multiple patents, including breakthroughs in lipid nanoparticle formulations and freeze-dried RNA vaccines, highlighting his commitment to advancing cutting-edge technologies. Rushit has also been invited to serve as a guest editor for a special issue of MDPI Pharmaceutics, focusing on next-generation vaccine adjuvants, reflecting his thought leadership in the field. His role as a mentor and collaborator has further solidified his reputation, as he supervises Ph.D. students and contributes to the scientific community through impactful publications and book chapters. These accolades underscore his dedication to innovation, collaboration, and advancing pharmaceutical sciences to address global health challenges.

Conclusion

Rushit N. Lodaya is a highly suitable candidate for the Best Researcher Award. His exceptional contributions to vaccine formulation, particularly in mRNA and LNP technologies, and his leadership in advancing innovative drug product solutions make him a strong contender. While he can expand his translational and collaborative impact, his sustained excellence, significant patents, publications, and mentorship strongly align with the award’s goals. Recognizing his efforts would celebrate and encourage further advancements in the critical field of vaccine R&D.

Publications top noted

  • The continued advance of vaccine adjuvants–‘we can work it out’
    • Authors: DT O’Hagan, RN Lodaya, G Lofano
    • Year: 2020
    • Citations: 117
  • “World in motion”–emulsion adjuvants rising to meet the pandemic challenges
    • Authors: DT O’Hagan, R van der Most, RN Lodaya, M Coccia, G Lofano
    • Year: 2021
    • Citations: 73
  • Formulation design, optimization and in vivo evaluations of an α-tocopherol-containing self-emulsified adjuvant system using inactivated influenza vaccine
    • Authors: RN Lodaya, AP Kanitkar, K Friedrich, D Henson, R Yamagata, S Nuti, …
    • Year: 2019
    • Citations: 26
  • Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant
    • Authors: Y Wen, HV Trinh, CE Linton, C Tani, N Norais, DA Martinez-Guzman, …
    • Year: 2018
    • Citations: 17
  • Stable nanoemulsions for the delivery of small molecule immune potentiators
    • Authors: RN Lodaya, LA Brito, TYH Wu, AT Miller, GR Otten, M Singh, DT O’Hagan
    • Year: 2018
    • Citations: 14
  • Overview of vaccine adjuvants
    • Authors: RN Lodaya, S Gregory, MM Amiji, DT O’Hagan
    • Year: 2022
    • Citations: 7
  • Practical aspects of vaccine development
    • Authors: P Kolhe, S Ohtake
    • Year: 2021
    • Citations: 5
  • A Self-Emulsified Adjuvant System Containing the Immune Potentiator Alpha Tocopherol Induces Higher Neutralizing Antibody Responses than a Squalene-Only Emulsion When Evaluated
    • Authors: RN Lodaya, AP Kanitkar, A Ashraf, D Bamba, MM Amiji, DT O’Hagan
    • Year: 2023
    • Citations: 3
  • Lyophilized vaccine development
    • Authors: NM Payton, RN Lodaya, AM Padilla
    • Year: 2022
    • Citations: 3
  • Nanoscale Vaccines for Influenza
    • Authors: S Bhangde, RN Lodaya, MM Amiji
    • Year: 2023
    • Citations: 1
  • Microfluidic-Chip-Based Formulation and In Vivo Evaluations of Squalene Oil Emulsion Adjuvants for Subunit Vaccines
    • Authors: S Bhangde, S Fresnay-Murray, T Garretson, A Ashraf, DT O’Hagan, …
    • Year: 2024
    • Citations: Not yet available
  • Freeze-drying of lipid nanoparticles (lnps) encapsulating rna and formulations thereof
    • Authors: R Lodaya, P Pohlhaus, E Zecca, J Zhang, A Padilla, E Bourlès, J Enert
    • Year: 2024
    • Citations: Not yet available
  • “World in motion”-emulsion adjuvants rising to meet the pandemic challenges (Vol 6, 158, 2021)
    • Authors: DT O’Hagan, R van der Most, RN Lodaya, M Coccia, G Lofano
    • Year: 2023
    • Citations: Not yet available
  • Author Correction: “World in motion”–emulsion adjuvants rising to meet the pandemic challenges
    • Authors: DT O’Hagan, R van der Most, RN Lodaya, M Coccia, G Lofano
    • Year: 2023
    • Citations: Not yet available
  • Review 2: “A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability”
    • Authors: HM Niknam, NS Savar
    • Year: 2022
    • Citations: Not yet available

Eman Mohamed Ismail Fayad | Pharmaceutical Science | Best Researcher Award

Eman Mohamed Ismail Fayad | Pharmaceutical Science | Best Researcher Award

Assistant Professorr at Taif University, Egypt.

Dr. Eman Mohamed Ismail Fayad, an Assistant Professor at the Department of Biotechnology, Faculty of Science, Taif University, is a committed academic with a dynamic career in biotechnology and zoology. Born in Dakahliah, Egypt, she has built a distinguished career through both teaching and research. Her professional journey spans Egypt and Saudi Arabia, bringing a unique blend of local and international experience to her work. With over a decade at Taif University, Dr. Fayad is well-regarded for her expertise in biotechnology, a field that bridges biological sciences with technological advancements. Her dedication to education, research, and scientific community engagement is further highlighted by her active membership in professional societies, like the El Alamein Union in Egypt. Dr. Fayad’s accomplishments and commitment to the scientific community underscore her eligibility for awards that celebrate research excellence.

Professional Profile

Education

Dr. Fayad’s educational foundation in the biological sciences has been pivotal to her success in academia and research. With an early focus on zoology, she began her academic journey at Mansoura University in Egypt, where she completed her undergraduate and advanced studies. She has cultivated an in-depth understanding of biological sciences, ultimately specializing in biotechnology, a field that allows her to leverage her strong zoological background with technological applications. Her academic training at Mansoura University, a leading institution in Egypt, has equipped her with both theoretical and practical insights necessary for her role as an Assistant Professor. This strong educational background provides a robust base for her teaching and research activities, supporting her contributions to biotechnology and her role in shaping future scientists.

Professional Experience

Dr. Fayad’s experience spans teaching and research roles in both Egypt and Saudi Arabia, positioning her as a versatile academic with international exposure. She began her career in 2007 at Mansoura University, where she taught zoology in the Faculty of Science. In 2011, Dr. Fayad joined the Faculty of Science at Taif University in Saudi Arabia as an Assistant Professor in the Biotechnology Department. This move broadened her academic experience and allowed her to engage with diverse student bodies and academic networks. Her over ten years at Taif University underscore her commitment to teaching and academic research, where she continuously fosters a learning environment that integrates biotechnology advancements with biological sciences.

Research Interest

Dr. Fayad’s research interests focus primarily on biotechnology and its applications in biological sciences, particularly in zoology. This interdisciplinary approach enables her to contribute to projects that require both technological innovation and a deep understanding of biological systems. Her work often involves exploring biotechnological solutions to biological and ecological challenges, a focus that aligns with current scientific priorities for sustainable solutions. Her interest in these areas reflects her commitment to advancing scientific knowledge while addressing real-world challenges through research. Dr. Fayad is keen on using biotechnology to solve complex biological problems, making her research both relevant and impactful in today’s science landscape.

Award and Honor

Throughout her career, Dr. Fayad has received recognition for her contributions to academia and the scientific community. While specific awards were not listed, her longstanding role as an Assistant Professor at Taif University and her membership in professional societies highlight the acknowledgment she has earned from academic institutions and peers. Dr. Fayad’s active engagement in the scientific community, particularly through the El Alamein Union in Egypt, speaks to her reputation and contributions in the field. Her professional accolades not only demonstrate her dedication to her research but also reinforce her commitment to academic excellence and innovation in biotechnology and zoology. These honors position her as a distinguished figure within her field, with a promising trajectory for further achievements.

Conclusion

Dr. Fayad’s academic background, international teaching experience, and interdisciplinary knowledge make her a strong candidate for the Best Researcher Award, particularly if she has contributed to impactful research in biotechnology or zoology. Enhancing her profile with a list of recent publications and additional professional memberships could further solidify her standing among competitors.

Publications top noted

Title: Modelling the COVID‐19 Mortality Rate with a New Versatile Modification of the Log‐Logistic Distribution
Authors: AH Muse, AH Tolba, E Fayad, OA Abu Ali, M Nagy, M Yusuf
Year: 2021
Citations: 48

Title: Proteome based approach defines candidates for designing a multitope vaccine against the Nipah virus
Authors: MA Soltan, MA Eldeen, N Elbassiouny, I Mohamed, DA El-Damasy, E Fayad
Year: 2021
Citations: 38

Title: Statistical optimization of bile salt deployed nanovesicles as a potential platform for oral delivery of piperine: accentuated antiviral and anti-inflammatory activity in MERS
Authors: MY Zakaria, E Fayad, F Althobaiti, I Zaki, AH Abu Almaaty
Year: 2021
Citations: 30

Title: Anti-proliferative and immunomodulatory potencies of cinnamon oil on Ehrlich ascites carcinoma bearing mice
Authors: Dalia S. Morsi, Sobhy Hassab El‑Nabi, Mona A. Elmaghraby, Ola A. Hassan, E Fayad
Year: 2022
Citations: 28

Title: Recognition of mRNA N4 acetylcytidine (ac4C) by using non-deep vs. Deep learning
Authors: MS Iqbal, R Abbasi, MB Bin Heyat, F Akhtar, AS Abdelgeliel, S Albogami, E Fayad
Year: 2022
Citations: 27

Title: In Silico Designing of a Multitope Vaccine against Rhizopus microsporus with Potential Activity against Other Mucormycosis Causing Fungi
Authors: MA Soltan, MA Eldeen, N Elbassiouny, HL Kamel, KM Abdelraheem, E Fayad
Year: 2021
Citations: 27

Title: Gamma irradiation assisted the sol–gel method for silver modified-nickel molybdate nanoparticles synthesis: Unveiling the antimicrobial, and antibiofilm activities against some pathogens
Authors: MIA Abdel Maksoud, GS El-Sayyad, E Fayad, A Alyamani, OA Abu Ali
Year: 2021
Citations: 27

Title: Antibacterial, antifungal and antibiofilm activities of silver nanoparticles supported by crude bioactive metabolites of bionanofactories isolated from Lake Mariout
Authors: M Eltarahony, A Ibrahim, H El-Shall, E Ibrahim, F Althobaiti, E Fayad
Year: 2021
Citations: 25

Title: Design and synthesis of newly synthesized acrylamide derivatives as potential chemotherapeutic agents against MCF-7 breast cancer cell line lodged on PEGylated bilosomal nano
Authors: I Zaki, RAI Abou-Elkhair, AH Abu Almaaty, O A. Abu Ali, E Fayad
Year: 2021
Citations: 21

Title: Comparative study between curcumin and nanocurcumin loaded PLGA on colon carcinogenesis induced mice
Authors: FE Elbassiouni, WM El-Kholy, ESM Elhabibi, S Albogami, E Fayad
Year: 2022
Citations: 20

Lakshmanan Govindan | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Dr.  Lakshmanan Govindan | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Assistant Professor at Saveetha Medical College and Hospital, India

Dr. Sheryene Tejeda, PhD, is an accomplished medical scientist with over 15 years of experience in clinical and scientific environments. Based in Palm Beach Gardens, Florida, she has played key roles in advancing medical research and developing innovative therapeutic protocols. Her expertise spans diverse fields such as oncology, neurology, and behavioral health. Dr. Tejeda has been instrumental in her positions, including Lead Medical Scientist at Medicinal Technologies, Contract Co-occurring Consultant, and Clinical Research Associate, where she contributed to cutting-edge research and patient care strategies. Her career is marked by a deep commitment to integrating science and holistic health approaches.

Professional Profile

Education

Dr. Tejeda’s academic background is as impressive as her professional career. She earned her PhD in Biomedical Science from Einstein Medical School, laying a strong foundation for her research in complex medical conditions. Additionally, she holds two Master’s degrees—one in Forensic Science and another in Health Science. These advanced studies equipped her with a multidisciplinary approach to healthcare, combining rigorous scientific methodology with a focus on human health outcomes. Dr. Tejeda also earned a Bachelor’s degree in Communications and Psychology, highlighting her interest in understanding human behavior alongside her scientific expertise.

Professional Experience

Dr. Tejeda’s extensive professional experience includes leadership roles in both clinical research and therapeutic development. As Lead Medical Scientist at Medicinal Technologies, she spearheaded research initiatives aimed at improving patient care through innovative medicinal approaches. Her role as a Contract Co-occurring Consultant involved working with individuals facing both mental health and substance use challenges, underscoring her commitment to integrative healthcare. In addition to her clinical work, Dr. Tejeda served as a Clinical Research Associate, contributing to various oncology and neurology trials. Her work across these roles highlights her versatility and leadership in advancing medical science.

Research Interests

Dr. Tejeda’s research interests are diverse and deeply rooted in her passion for integrative therapies and patient-centered care. She is particularly focused on oncology, where she investigates novel therapeutic approaches to cancer treatment. Additionally, she has a keen interest in neurology, exploring the intersections of neuroscience, behavior, and mental health. Her research also extends into behavioral health, where she looks at co-occurring disorders and the development of more effective treatment protocols. Dr. Tejeda’s interdisciplinary approach allows her to contribute meaningful insights into complex health challenges, with a focus on improving both treatment outcomes and patient quality of life.

Awards and Honors

Throughout her career, Dr. Tejeda has received numerous awards and recognitions for her contributions to medical research and healthcare. Her innovative work in oncology and neurology has been particularly lauded, earning her accolades within the scientific community. Additionally, her efforts in integrative and patient-focused care have resulted in recognition for her commitment to improving therapeutic practices. While specific awards have marked her journey, it is her ongoing dedication to advancing medical science and holistic health that continues to distinguish her as a leader in her field. Her work remains an inspiration to her colleagues and the broader medical community.

Conclusion

Dr. Lakshmanan’s extensive experience in medicinal plant research, advanced laboratory techniques, and interdisciplinary publications make him a deserving candidate for the Best Researcher Award. His innovative work in cancer and diabetes treatments has potential for wide-reaching applications in healthcare. Strengthening his grant acquisition and international research collaborations would further solidify his standing as a leading researcher in his field.

Publication top noted

  • Kamakshi, S., Anantha Lakshmi, P., Shenbhagaraman, R., Lakshmanan, G., Selvakumari, J.
    Antibacterial and photo dye degradative ability of copper oxide nanoparticles from Pleurotus cystidiosus
    Nano Express, 2024, 5(2), 025029
    📝 0 Citations
  • Muthu, S., Gopal, V., AL-Younis, Z.K., Giuffrè, A.M., Govindan, L.
    Extraction, purification, and investigation of the antibacterial potential of lysozyme isolated from the latex of Calotropis procera
    European Food Research and Technology, 2024, 250(5), pp. 1401–1416
    📝 0 Citations
  • Lakshmanan, G., Altemimi, A.B., Sivaraj, C., Najm, M.A.A., Gamal Abedelmaksoud, T.
    Imperatorin from the aerial parts of Cleome viscosa L.: a characterization study and evaluation of the antibacterial activity
    Natural Product Research, 2024, 38(5), pp. 848–855
    📝 0 Citations
  • Maria Francis, Y., Karunakaran, B., Ashfaq, F., Govindan, L., Ponnusamy Kasirajan, S.
    Mercuric Chloride Induced Nephrotoxicity: Ameliorative Effect of Carica papaya Leaves Confirmed by Histopathology, Immunohistochemistry, and Gene Expression Studies
    ACS Omega, 2023, 8(24), pp. 21696–21708
    📝 3 Citations
  • Sivalingam, A.M., Altemimi, A.B., Abdul-Abbas, S.J., Cacciola, F., Devaraj, N.
    Anti-Hyperglycaemic properties of an ethanolic extract from Costus spicatus (jacq) on Streptozotocin-induced diabetic male albino Wistar rats
    Moroccan Journal of Chemistry, 2023, 11(4), pp. 917–931
    📝 0 Citations
  • Rengarajan, S., Thangavel, N., Sivalingam, A.M., Selvakumari, J., Pandian, A.
    Green synthesis and characterization of silver nanoparticles with different solvent extracts of Sesbania grandiflora (L.) Poiret and assessment of their antibacterial and antioxidant potentials
    Biomass Conversion and Biorefinery, 2023
    📝 5 Citations
  • Lakshmanan, G., Selvam, R., Altemimi, A.B., Jayalakshmi, G., Pratap-Singh, A.
    Phytochemical screening of ethanolic extracts of Cuminum cyminum L. seeds along with the evaluation of antidiabetic properties by molecular docking approach
    Natural Product Research, 2023, 37(4), pp. 681–686
    📝 3 Citations
  • Vijayaraj, R., Altaff, K., Lakshmanan, G., Palanisamy, M., Alothaim, A.S.
    Inhibitory Activity of Chitin, (2-Acetamido-2-Deoxy-Hexopyranose) against Penicillin-Binding Proteins of Staphylococcus aureus
    Coatings, 2022, 12(12), 1854
    📝 4 Citations
  • Radhakrishnan, M., Palayam, M., Altemimi, A.B., Cacciola, F., Govindan, L.
    Leucine-Rich, Potent Anti-Bacterial Protein against Vibrio cholerae, Staphylococcus aureus from Solanum trilobatum Leaves
    Molecules, 2022, 27(4), 1167
    📝 2 Citations
  • Rama, P., Baldelli, A., Vignesh, A., Murugesan, K., Pratap-Singh, A.
    Antimicrobial, antioxidant, and angiogenic bioactive silver nanoparticles produced using Murraya paniculata (L.) jack leaves
    Nanomaterials and Nanotechnology, 2022
    📝 14 Citations

Xin Jin | Pharmaceutical Science | Industry Innovation Recognition Award

🌟Ms. Xin Jin, Sanofi, United States: Pharmaceutical Science🏆
Professional Profiles:
Bio Summary:

Xin Jin is a highly accomplished professional with a background in Chemical Engineering and extensive experience in the pharmaceutical and research industries. With a Ph.D. in Chemical Engineering from Ohio University, Xin has contributed significantly to the fields of drug product development, analytical method validation, and process engineering. Xin’s expertise encompasses a wide range of areas, including AAV drug product development, lipid nano particle (LNP) drug development, and high concentration protein product platform development.

Title: Freeze Drying and Vial Breakage: Misconceptions, Root Causes, and Mitigation Strategies for the Pharmaceutical Industry

Abstract:

Vial breakage during or following freeze drying (lyophilization) is a well-known phenomenon in the pharmaceutical industry, yet the underlying mechanism and root causes are not well characterized. While commonly attributed to crystallizing excipients like mannitol, other potential factors are often underestimated or not well studied. This research presents a systematic multipronged approach to characterize and identify potential root causes of vial breakage during lyophilization.

Key Points:

Multipronged Approach: The study employs a systematic and comprehensive approach, considering various factors associated with formulation, product configuration, primary container, and production process stress conditions.

Laboratory and Manufacturing Scale Studies: Investigations are conducted both at the laboratory and manufacturing scales to provide a holistic understanding of the vial breakage phenomenon.

Factors Investigated:

Strain gauge and lyophilization analysis for stress on glass vials with different formulation conditions and fill volumes.

Manufacturing fill-finish process risk assessment, including loading and frictive force impact on the vials.

Glass vial design and ruggedness, involving glass compression resistance or burst strength testing.

Complexity of Vial Breakage Causes: No single factor could be independently related to the extent of vial breakage observed during production. Instead, a combination of formulation, fill volume, and at-scale production processes were identified as the most probable root causes.

Identification of Probable Root Causes:

Formulation

Fill volume

Vial weakening processes encountered during at-scale production, such as vial handling, shelf loading, and unloading.

Contradiction to Simplistic Explanations: The study challenges simplistic root-cause explanations reported in literature and emphasizes the need for a more nuanced understanding of vial breakage.

Mitigative Approaches: The research provides insights into the possibility of implementing mitigative approaches to minimize or eliminate vial breakage associated with lyophilized drug products.

Education:

  • Ph.D. Chemical Engineering, Ohio University, September 2009
  • M.S. Physical Chemistry, University of Science and Technology, Beijing, March 2001
  • B.S. Chemical Engineering, Beijing Institute of Petrochemical Technology, August 1998
Research Focus:

Xin Jin’s research has focused on various aspects of chemical engineering, including coal electrolysis for hydrogen production, electrochemical analytical methods, and the design and application of Z-Path Moving Bed (ZMB) in drying and dust removal processes. The research has resulted in publications and patents, showcasing Xin’s commitment to advancing scientific knowledge.

Professional Journey:

Xin Jin has held key roles in prominent organizations, including Sanofi, Fresenius Kabi, Shire Pharmaceuticals, and Armstrong Pharmaceutical Inc. The roles have spanned from Research Engineer to Scientist in BioDrug Product Development, highlighting Xin’s versatility and leadership in areas such as formulation studies, lyophilization process modeling, and analytical method development.

Publications Top Noted & Contributions:

Xin Jin has made significant contributions to the field, with notable publications such as “Understanding the Kinetics of Coal Electrolysis at Intermediate Temperatures” and “Feasibility of Hydrogen Production from Coal Electrolysis at Intermediate Temperatures.” Additionally, Xin has a patent pending for an electrochemical technique to measure the concentration of multivalent cations simultaneously.

Understanding the kinetics of coal electrolysis at intermediate temperatures” (Journal of Power Sources, 2010, 195(15), pp. 4935–4942)

  • 54 Citations

“Electrochemical technique to measure Fe(II) and Fe(III) concentrations simultaneously” (Journal of Applied Electrochemistry, 2009, 39(10), pp. 1709–1717)

  • 15 Citations

“Fuel Cells – Exploratory Fuel Cells | Direct Carbon Fuel Cells” (Encyclopedia of Electrochemical Power Sources, 2009, pp. 158–171)

  • 15 Citations

“Feasibility of hydrogen production from coal electrolysis at intermediate temperatures” (Journal of Power Sources, 2007, 171(2), pp. 826–834)

  • 47 Citations
Author Metrics:
  • Total documents: 4
  • Cited by 94 documents
  • h-index: 4
Research Timeline:
  • Research Assistant, Electrochemical Engineering Research Laboratory, Ohio University (March 2005 to September 2009)
    • Dissertation Project: Feasibility of coal electrolysis to produce hydrogen at intermediate temperatures.
  • Research Assistant, Institute of Process Engineering, Chinese Academy of Sciences (September 1998 to March 2001)
    • Master’s Project: Z-Path Moving Bed (ZMB) Design and its Application in Drying and Dust Removal Process.
  • Quality Testing Lab Manager, Beijing University Pioneer Technology Company, Ltd. (September 2002 to March 2003)
  • Process Engineer, Beijing University Pioneer Technology Company, Ltd. (March 2001 to March 2003)